Conjunctivitis Drugs Market Size, Share, And Trends Analysis Report By Type (Viral, Allergic, Bacterial, Others) By Drug Class (Antibiotics, Quinolones, Aminoglycosides, Others, Steroids, Mast cell stabilizers, others) By Route of Administration (Oral, Topical, Intra-vitreal) By End-User (Hospitals, Self-administered) Based On Region, And Segment Forecasts, 2022 - 2028

  • Report ID: BMRC 531 | Number of pages: 199 | Published Date: Jan 2022

    Published | Category: Healthcare | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On Conjunctivitis Drugs Market Size, Share, And Trends Analysis Report By Type (Viral, Allergic, Bacterial, Others) By Drug Class (Antibiotics, Quinolones, Aminoglycosides, Others, Steroids, Mast cell stabilizers, others) By Route of Administration (Oral, Topical, Intra-vitreal) By End-User (Hospitals, Self-administered) Based On Region, And Segment Forecasts, 2022 - 2028 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

Conjunctivitis Drugs Market is valued at USD 4270.0  Million in 2021 and expected to reach USD 5432.6 Million by 2028 with a CAGR of 3.5% over the forecast period.

Conjunctivitis Drugs Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027. Poor hygienic conditions and low awareness among people of developing and underdeveloped countries about conjunctivitis boost the market growth.

Scope of Global Conjunctivitis Drugs Market Report:-

Conjunctivitis is an eye-related disease especially found and spreads in children. Conjunctiva is a layer of tissues that is transparent and lines the inner surface of the eyelid and covers the white part of the eye which becomes red or pink and gets swollen in conjunctivitis. It can be caused by bacteria and viruses and get spread easily from person to person but not that much risky for health if get treated properly. Rare but risky conjunctivitis can transmit because of Gonorrhea via bacteria. In adults, Chlamydia can cause this disease. The main reasons behind the disease are bacteria or viruses, fungi, amoebas, parasites, shampoos, dirt, smoke, pool chlorine, and some allergic reaction causing factors pollen grains can also transfer conjunctivitis. Some common types of conjunctivitis are viral strains that are most contagious and common, leading to teary eyes and watery discharge.

Global Conjunctivitis Drugs Market report is segmented on the basis of type, drug class, route of administration, end-user, and regional & country level. Based upon type, the conjunctivitis drugs market is segmented into viral, bacterial, allergic, and others. Based on drug class, the conjunctivitis drugs market is segmented into antibiotics, mast cell stabilizers, steroids, and others. Based on route of administration, the market is classified into topical, oral, and intra-vitreal. Based upon end-user, the conjunctivitis drugs market is segmented into hospitals and self-administered.

The regions covered in this Conjunctivitis Drugs Market report are North America, Europe, Asia-Pacific, and the Rest of the World. On the basis of country level, the market of  Conjunctivitis Drugs is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Conjunctivitis Drug Companies

Some major key players for the Conjunctivitis Drugs market are

  • Akorn Pharmaceuticals
  • Alcon/ Novartis AG
  • Allergan Plc
  • Bausch & Lomb
  • Valeant Pharmaceuticals
  • Merck & Co. Inc.
  • Actavis Plc.
  • Pfizer Inc.
  • others.

Conjunctivitis Drugs Market

Conjunctivitis Drugs Market Segmentation:

By Type:

  • Viral
  • Allergic
  • Bacterial
  • Others

By Drug Class:

  • Antibiotics
  • Quinolones
  • Aminoglycosides
  • Others
  • Steroids
  • Mast cell stabilizers
  • others

By Route of Administration:

  • Oral
  • Topical
  • Intra-vitreal

By End-User:

  • Hospitals
  • Self-administered

Market Dynamics –

Around 5 million cases of bacterial conjunctivitis are registered every year. Initiatives are taken by the healthcare institutions to spread awareness among people for the treatment of conjunctivitis in developing and underdeveloped countries increase the demand for conjunctivitis drugs and foster market growth. The health conditions of the developing and underdeveloped countries are poor and have a lack of awareness which leads to infectious diseases. Also, the rising focus of the healthcare sector on eye care reciprocating in a positive way. The rise in healthcare expenditure and the contagious/ spreading characteristic of the disease have strongly supplemented the growth of the drugs market. However, the process of drug making for conjunctivitis is very complicated which may hamper the market growth. Moreover, for viral conjunctivitis, no drug is available currently. Powerful investments of pharmaceutical companies and vigorous channels with various drugs in the development process are anticipated to give sufficient growth to the market in the upcoming period. Huge investments are running on R&D activeness that is deposited to push the market forward.

Regional Analysis-

The global conjunctivitis drugs market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle east & Africa. North America is anticipated to dominate the global conjunctivitis drugs market owing to the running clinical trials and accessibility & amplified applications of diagnostic tests. North America holds the largest share followed by Europe due to its saturated and stagnant nature. About 1% of all primary care office stopovers in the US are connected to conjunctivitis which affects nearly 6 million people every year. In Europe, a huge patient pool diagnosed with viral conjunctivitis is supplementing the market growth. For example; As per WHO, around 9700 cases of conjunctivitis were registered in 2017 in Europe with an increase in the number of suspected cases considerably with 1680 and 2270 recorded weekly.

Asia-Pacific region is expected to witness significant growth in the market especially in the countries like India and China due to the growing population, widespread nature of conjunctivitis, and unmet medical needs. According to NCBI, ocular allergies affect nearly 6% to 30% population in the Asia-Pacific region.

Report Analysis Details
Historical data 2015 - 2020
Forecast Period 2021 - 2028
Market Size in 2021: USD 4270.0 Million 
Base year considered 2020
Forecast Period CAGR %:

3.5% 

Market Size Expected in 2028: USD 5432.6 Million 
Tables, Charts & Figures: 175
Pages 200
Conjunctivitis Drug Companies Akorn Pharmaceuticals, Alcon/ Novartis AG, Allergan Plc, Bausch & Lomb, Valeant Pharmaceuticals, Merck & Co. Inc., Actavis Plc., Pfizer Inc., and others.
Segments Covered By Type, By Drug Class, By Route of Administration, By End-User
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits for Conjunctivitis Drug Market Report:-

  • Conjunctivitis Drug Market report covers in-depth historical and forecast analysis.
  • Conjunctivitis Drug Market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country levels.
  • Conjunctivitis Drug Market report helps to identify opportunities in the marketplace.
  • Conjunctivitis Drug Market report covers extensive analysis of emerging trends and competitive landscape.

On Special Requirements Conjunctivitis Drugs Market Report is also available for the below Regions and Country:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherland
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest Of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest Of MEA


Frequently Asked Questions (FAQ) :
Conjunctivitis Drugs Market is valued at USD 4270.0  Million in 2021
Conjunctivitis Drugs Market Size, Share and Value to Reach USD 5432.6 Million by 2028 Growing at CAGR of 3.5% over the forecast period.
Poor hygienic conditions and low awareness among people of developing and underdeveloped countries about conjunctivitis boost the market growth.
Akorn Pharmaceuticals, Alcon/ Novartis AG, Allergan Plc, Bausch & Lomb, Valeant Pharmaceuticals, Merck & Co. Inc., Actavis Plc., Pfizer Inc., and others.
North America is anticipated to dominate the global conjunctivitis drugs market owing to the running clinical trials and accessibility & amplified applications of diagnostic tests.



Interested in this report?

Conjunctivitis Drugs Market Trends, Growth, Size, And Industry Analysis By 2028

report cover

Table of Content


Chapter 1 Global Conjunctivitis Drugs Market: Summary and Quantitative Analysis
1.1 Report Description
1.2 Global Conjunctivitis Drugs Market Revenue Overview
1.3 Global Conjunctivitis Drugs Market Revenue (USD Billion) and Growth (%) Rate, 2015- 2025

Chapter 2 Global Conjunctivitis Drugs Market: Overview and Qualitative Analysis
2.1 Executive Summary
2.2 Market Drivers
2.3 Market Restraints
2.4 Market Opportunities
2.5 Market Trends
2.6 Global Conjunctivitis Drugs Market: SWOT Analysis
2.7 Global Conjunctivitis Drugs Market: PEST Analysis
2.7 Global Conjunctivitis Drugs Market: Porter’s Five Forces Analysis
2.8 Global Conjunctivitis Drugs Market: Attractiveness Analysis
2.8.1 Global Conjunctivitis Drugs Market: Attractiveness Analysis by Type
2.8.2 Global Conjunctivitis Drugs Market: Attractiveness Analysis by Grade
2.8.3 Global Conjunctivitis Drugs Market: Attractiveness Analysis by Regional

Chapter 3 Competitive Analysis
3.1 Global Conjunctivitis Drugs Market
3.1.1 Global Conjunctivitis Drugs market Revenue (USD Billion), By Players 2018
3.1.2 Global Conjunctivitis Drugs Market Revenue Share (%), By Players 2018

Chapter 5 Global Conjunctivitis Drugs Market: By Product Type
5.1 Global Conjunctivitis Drugs Market Share (%), By Product Type, 2018
5.2 Global Conjunctivitis Drugs Market Revenue (USD Billion), By Product Type, 2015 – 2025
5.3 Global Conjunctivitis Drugs Market Revenue (USD Billion), By Retro,2015-2025
5.4 Global Conjunctivitis Drugs Market Revenue (USD Billion), 2015-2025
5.4 Global Conjunctivitis Drugs Market Revenue (USD Billion), 2015-2025
5.5 Global Conjunctivitis Drugs Market Revenue Share (%), By Product Type, 2015 – 2025
5.6 Global Conjunctivitis Drugs Market Revenue Market Share (%), By Product Type, 2015-2025

Chapter 6 Global Conjunctivitis Drugs Market: By Product Type
6.1 Global Conjunctivitis Drugs Market Share (%), By Product Type, 2018
6.2 Global Conjunctivitis Drugs Market Revenue (USD Billion), By Type, 2015 – 2025

Chapter 7 North America Conjunctivitis Drugs Market Analysis
7.1 North America Market Snapshot
7.1.1 North America Conjunctivitis Drugs Market Revenue and Growth Rate (%), 2015-2025.
7.1.2 North America Conjunctivitis Drugs Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
7.1.3 North America Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
7.1.5 North America Conjunctivitis Drugs Revenue (USD Billion) Overview, By Product Type, 2015-2025
7.1.6 North America Conjunctivitis Drugs Revenue (USD Billion) Overview, By Product Type , 2015-2025

Chapter 8 Europe Conjunctivitis Drugs Market Analysis
8.1 Europe Market Snapshot
8.1.1 Europe Conjunctivitis Drugs Market Revenue and Growth Rate (%), 2015-2025.
8.1.2 Europe Conjunctivitis Drugs Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
8.1.3 Europe Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
8.1.5 Europe Conjunctivitis Drugs Revenue (USD Billion) Overview, By Product Type, 2015-2025
8.1.6 Europe Conjunctivitis Drugs Revenue (USD Billion) Overview, By Type, 2015-2025

Chapter 9 Asia Pacific Conjunctivitis Drugs Market Analysis
9.1 Asia Pacific Market Snapshot
9.1.1 Asia Pacific Conjunctivitis Drugs Market Revenue and Growth Rate (%), 2015-2025.
9.1.2 Asia Pacific Conjunctivitis Drugs Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
9.1.3 Asia Pacific Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
9.1.5 Asia Pacific Conjunctivitis Drugs Revenue (USD Billion) Overview, By Product Type, 2015-2025
9.1.6 Asia Pacific Conjunctivitis Drugs Revenue (USD Billion) Overview, By Type, 2015-2025

Chapter 10 Latin America Conjunctivitis Drugs Market Analysis
10.1 Latin America Market Snapshot
10.1.1 Latin America Conjunctivitis Drugs Market Revenue and Growth Rate (%), 2015-2025.
10.1.2 Latin America Conjunctivitis Drugs Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
10.1.3 Latin America Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
10.1.5 Latin America Conjunctivitis Drugs Revenue (USD Billion) Overview, By Product Type, 2015-2025
10.1.6 Latin America Conjunctivitis Drugs Revenue (USD Billion) Overview, By Type, 2015-2025

Chapter 11 Middle East & Africa Conjunctivitis Drugs Market Analysis
11.1 Middle East & Africa Market Snapshot
11.1.1 Middle East & Africa Conjunctivitis Drugs Market Revenue and Growth Rate (%), 2015-2025.
11.1.2 Middle East & Africa Conjunctivitis Drugs Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
11.1.3 Middle East & Africa Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.

11.1.5 Middle East & Africa Conjunctivitis Drugs Revenue (USD Billion) Overview, By Product Type, 2015-2025
11.1.6 Middle East & Africa Conjunctivitis Drugs Revenue (USD Billion) Overview, By Type, 2015-2025

Chapter 12 Competitive Analysis
12.1 Company 1.
12.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
12.1.2 Company 1. Total Company Revenue 2015-2018
12.1.3 Company 1. Total Company Revenue, By Segment of Business 2015-2018
12.1.4 Company 1. Total Company Revenue, By Region 2015-2018
12.1.5 Company 1. Global Conjunctivitis Drugs Product Category and Description
12.1.6 Company 1. Recent Activity 2015-2019
12.1.7 Main Business/Business Overview
12.1.8 Business Strategy
12.1.9 SWOT Analysis
12.2 Company 2.
12.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
12.2.2 Company 2. Total Company Revenue 2015-2018
12.2.3 Company 2. Total Company Revenue, By Segment of Business 2015-2018
12.2.4 Company 2. Total Company Revenue, By Region 2015-2018
12.2.5 Company 2. Global Conjunctivitis Drugs Product Category and Description
12.2.6 Company 2. Recent Activity 2015-2019
12.2.7 Main Business/Business Overview
12.2.8 Business Strategy
12.2.9 SWOT Analysis
12.3 Company 3
12.3.1 Business Overview
12.3.2 Company 3Market Product Category and Description & Specification
12.3.3 Main Business/Business Overview
12.3.4 Business Strategy
12.3.5 SWOT Analysis
12.4 Company 4.
12.4.1 Business Overview
12.4.2 Company 4.Company Total Company Revenue 2015-2018
12.4.3 Company 4.Company Total Company Revenue, By Segment of Business 2015-2018
12.4.4 Company 4.Company Total Company Revenue, By Region of Business 2015-2018
12.4.5 Company 4.Company Product Category, Specification and Description
12.4.6 Company 4.Company Recent Mergers & Acquisitions (M&A) Activity 2015-2019
12.4.7 Company 4.Company Main Business/Business Overview
12.4.8 Business Strategy
12.4.9 SWOT Analysis
12.5 Company 5
12.5.1 Business Overview
12.5.2 Company 5 Company Net Sales 2015-2018
12.5.3 Company 5 Company Net Sales, By Segment of Business 2011-2018
12.5.4 Company 5 Company Net Sales, By Region 2015-2018
12.5.5 Company 5 Conjunctivitis Drugs Market Product Category and Specification
12.5.6 Company 5 Recent Mergers & Acquisitions (M&A) Activity 2015-2019
12.5.7 Company 5 Main Business/Business Overview
12.5.8 Business Strategy
12.5.9 SWOT Analysis
12.6 Company 6
12.6.1 Business Overview
12.6.2 Company 6 Conjunctivitis Drugs Market Product Category and Specification
12.6.3 Company 6 Recent Mergers & Acquisitions (M&A) Activity 2015-2019
12.6.4 Company 6 Main Business/Business Overview
12.6.5 Business Strategy
12.6.6 SWOT Analysis

Chapter 13 Market Research Findings & Conclusion

Chapter 14 Research Methodology
14.1 Research Process
14.2 Primary Research
14.3 Secondary Research
14.4 Market Size Estimates
14.5 Forecast Model
14.7 Who is This Report For?
14.8 USP’s of Report
?
List of Figures

FIG. 1 Global Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015- 2025
FIG. 4 Global Conjunctivitis Drugs Market: Attractiveness Analysis By Product Type
FIG. 5 Global Conjunctivitis Drugs Market: Attractiveness Analysis By Type
FIG. 6 Global Conjunctivitis Drugs Market: Attractiveness Analysis by Regional
FIG. 7 Global Conjunctivitis Drugs Market
FIG. 8 Global Conjunctivitis Drugs Market Share (%), By Product Type, 2018
FIG. 9 Global Conjunctivitis Drugs Market Revenue (USD Billion), By Application, 2015-2025
FIG. 10 Global Conjunctivitis Drugs Market Revenue (USD Billion), By End Use , 2015-2025
FIG. 10 Global Conjunctivitis Drugs Market Revenue (USD Billion), By Type, 2015-2025
FIG. 11 Global Conjunctivitis Drugs Market Revenue Market Share (%), By Product Type, 2015-2025
FIG. 20 North America Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 21 North America Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 22 Europe Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 23 Europe Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 24 Asia Pacific Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 25 Asia Pacific Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 26 Latin America Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 27 Latin America Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 28 Middle East & Africa Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 29 Middle East & Africa Conjunctivitis Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 30 Company 1. Total Company Revenue 2015-2018 (USD Million, R & D Expenses %)
FIG. 31 Company 1. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 32 Company 1. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %)
FIG. 33 Company 2. Total Company Revenue 2015-2018 (USD Million)
FIG. 34 Company 2. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 35 Company 2. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %) 119
FIG. 36 Company 3 Total Company Revenue 2015-2018 (USD Million)
FIG. 37 Company 3 Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 38 Company 3 Total Company Revenue, by Region of Business 2015-2018 (USD Million, AGR %)
FIG. 39 Company 4. Company Net Sales 2015-2018 (USD Million, R & D Expenses %)
FIG. 40 Company 4. Company Net Sales, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 41 Company 4. Company Net Sales, by Region 2015-2018 (USD Million, AGR %)
FIG. 42 Company 5 Total Company Revenue 2015-2018 (USD Million, R & D Expenses %)
FIG. 43 Company 5 Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 44 Primary Research
FIG. 45 Sources of Secondary Research
FIG. 46 Forecast Model

List of Tables

TABLE 1 Global Conjunctivitis Drugs Market Overview
TABLE 2 Market Driver Impact Analysis
TABLE 3 Market Restraints Impact Analysis
TABLE 4 Global Conjunctivitis Drugs market Revenue (USD Billion), By Players2018
TABLE 5 Global Conjunctivitis Drugs market Revenue Market share (%), By Players- 2018
TABLE 6 Global Conjunctivitis Drugs Market Revenue (USD Billion), By Product Type, 2015 - 2025
TABLE 7 Global Conjunctivitis Drugs Market Revenue Share (%), By Product Type, 2015 - 2025
TABLE 8 Global Conjunctivitis Drugs Market Revenue (USD Billion), By Product Type, 2015 - 2025
TABLE 9 Global Conjunctivitis Drugs Market Revenue Share (%), By Product Type, 2015 - 2025
TABLE 10 Global Conjunctivitis Drugs Market Revenue (USD Billion), 2015 - 2025
TABLE 11 Global Conjunctivitis Drugs Market Revenue Share (%), By , 2015 - 2025
More …………...

Conjunctivitis Drugs Market Size, Share, And Trends Analysis Report By Type (Viral, Allergic, Bacterial, Others) By Drug Class (Antibiotics, Quinolones, Aminoglycosides, Others, Steroids, Mast cell stabilizers, others) By Route of Administration (Oral, Topical, Intra-vitreal) By End-User (Hospitals, Self-administered) Based On Region, And Segment Forecasts, 2022 - 2028

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.

    Pricing


Looking for Regional Reports?